Development, characterization and in VIVO evaluation of diffusion controlled transdermal matrix patches of a model anti-Inflammatory drug
Keywords:
Transdermal, Lornoxicam, drug diffusion, anti-inflammatory, analgesic activity, matrix patchesAbstract
In the current research, diffusion controlled transdermal matrix patches of Lornoxicam, an anti-inflammatory drug was developed by solvent casting method using hydrophilic and hydrophobic polymers in different ratios and tween-80 and span-80 as permeation enhancers. Formulated patches were characterized for different physicochemical parameters in terms of moisture loss, drug content, film thickness and strength, uptake and loss of moisture, transmission of water vapor etc. All of these parameters were found be satisfactory. In-vitro diffusion studies of formulated patches were performed by using Franz diffusion cells. The drug diffusion rate followed zero order kinetics with super case II transport diffusion. Based on In-vitro diffusion data, best formulation was selected and used further for the stability analysis. Developed patches were stable at different temperature and humidity settings in terms of physicochemical properties and drug content. The optimized patches were also evaluated for the in-vivoanti-inflammatory and analgesic activity using suitable animal models. The results of all the in-vitro and in-vivo studies justify the selection of transdermal route for the systemic delivery of Lornoxicam to overcome its shortcomings when administered orally.
Downloads
References
Pagar R, Ghule RS, Bairagi VA, et al, 2018. Formulation and development of sustained release matrix tablets of lornoxicam. J Drug Deliv Ther. 8(2), Pages- 102-6.
Hamza YS, Aburahama MS, 2010. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers. Pharm Devlop Tech. 15(2), Pages- 139-53.
Kumar P, 2018. Solid lipid nanopartical in corporated cream of clobetasol-17-propionate: development and in-vitro evaluation. Int J Pharm Sci Res. 9(12), Pages- 5444-48.
Hamza YS, Aburahama, 2010. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads. Pharm Devlop Tech.15(3), Pages- 1-15.
Moore N, Pollack C, Butkerait P, 2015. Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 11, Pages- 1061-75.
Ricciotti E, Garret GA, Gerald F, 2011. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 31(5), Pages- 986-1000.
Kumar P, Bhutani R, 2013. Studies on penetration enhancers in corporated cream of clobetasol-17-propionate: development and in vitro evaluation. Int J Pharm Sci Res. 4(6), Page- 2258.
Prabhakara P, Koland M, Ahmed MG, et al, 2010. Preparation and evaluation of transdermal patches of papaverine hydrochloride. Int J Res Pharm Sci. 1(3), Pages- 259-66.
Shrivastava B, Kumar P, Gupta MM, et al, 2019. Transdermal patch of timolol maleate: formulation and evaluation. APJHS. 6(1), Pages-177-88.
Bharkatiya M, Nema RK, Bhatnagar M, 2010. Development and characterization of transdermal patches of metoprolol tartrate. Asian J Pharm Clin Res. 3(2), Pages- 130-4.
Kumar PA, Shrivastava BI, Gupta MM, Sharma AK, 2019. Optimization and preparation of solid lipid nanoparticle incorporated transdermal patch of timolol maleate using factorial design. Int J Appl Pharm. 11(6), Pages- 100-7.
Parhi R, Suresh P, 2016. Transdermal delivery of diltiazem HCl from matrix film: Effect of penetration enhancers and study of antihypertensive activity in rabbit model. J Adv Res.7(3), Pages- 539-50.
Nguyen HX, Puri A, Banga AK, 2017. Methods to simulate rubbing of topical formulation for in vitro skin permeation studies. Int J Pharm. 519(1-2), Pages- 22-33.
Romero AI, Villegas M, Cid AG, et al, 2018. Validation of kinetic modeling of progesterone release from polymeric membranes. Asian J Pharm Sci. 13(1), Pages- 54-62.
Ma X, Wang H, Song Y, et al, 2021. Skin irritation potential of cosmetic preservatives: an exposure‐relevant study. J Cosmet Dermatol. 20(1), Pages- 195-203.
Bharkatiya M, Nema RK, Bhatnagar M, 2010. Designing and characterization of drug free patches for transdermal application. Int J Pharm Sci Drug Res. 2(1), Pages- 35:39.
Park I, Dongwan K, Jindeog S, et al, 2008. Buprederm, a new transdermal delivery system of bprenorphine: pharmacokinetic, efficacy and skin irritation studies. Pharm Res. 25(5), Pages- 1052-62.
Laithy HME, 2009. Novel transdermal delivery of timolol maleate using sugar esters: preclinical and clinical studies. Eur J Pharm Sci. 72, Pages- 239-45.
Gupta GD, Gaud RS, 2006. Anti-inflammatory activity of tenoxicam gel on carrageenan induced paw-oedema in rats. Indian J Pharm Sci. Pages- 356-9.
Ashrafizadeh M, Najafi M, Kavyiani N, et al, 2021. Anti-inflammatory activity of melatonin: A focus on the role of NLRP3 inflammasome. Inflammation. 44(4), Pages- 1207-22.
ChoudharyD, Dutta KN, Kalita R, 2021. A review on transdermal patches used as an anti-inflammatory agent. Asian J Pharm Clin Res. 14(12), Pages- 21-6.
Baricevic D, Sosa S, Tubaro A, et al, 2001. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol. 75(2-3), Pages- 125-32.
Ebtsam M, Iman I, Nadia A, 2010. Formulation and stability study of chlorpheniramine maleate ransdermal patch. Asian J Pharm. 4(1), Pages- 17-23.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
